Volume 21
-
No. 12 December 2022
Predictive validity in the search for drug discovery oases, inspired by the Perspective on p915.
-
No. 11 November 2022
Macrophages as tools and targets, inspired by the Review on p799.
-
No. 10 October 2022
Avidity in antibody drug design, inspired by the Review on p715.
-
No. 9 September 2022
Antibodies to combat viral infections, inspired by the Review on p676.
-
No. 8 August 2022
Drugging the efferocytosis process, inspired by the Review on p601.
-
No. 7 July 2022
Immune checkpoint inhibitors, inspired by the Focus issue.
-
No. 6 June 2022
RNA-silencing oligonucleotides in metabolic disease, inspired by the Review on p417.
-
No. 5 May 2022
Therapeutically harnessing extracellular vesicles, inspired by the Review on p379.
-
No. 4 April 2022
Neoantigens for therapeutic cancer vaccines, inspired by the Review on p261.
-
No. 3 March 2022
Immune targets for antidepressants, inspired by the Review on p224.
-
No. 2 February 2022
Targeting cancer metabolism, inspired by the Review on p141.
-
No. 1 January 2022
Targeting TRP channels, inspired by the Review on p41.